poisar

Stocks · News reference

8-K filing — TELA Bio, Inc. (TELA)

SEC EDGARSEC EDGAR

Filed: 2026-10-06 AccNo: 0001104659-26-114042 Size: 186 KB Item 8.01: Other Events

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

    TELA Bio announced FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh device for soft tissue reinforcement. Liora is the first fully resorbable synthetic product in the company's portfolio to be designed and produced in-house at its ISO 8 certified cleanroom in Malvern, PA, expanding TELA Bio's soft tissue reconstruction market footprint.